Article and Video CATEGORIES

Cancer Journey

Search By

SBRT as a Potential Alternative for Fit Patients with Early Stage Lung Cancer
Thu, 01/28/2016 - 06:00
GRACE Videos and Articles
GRACE Cancer Video Library - Lung



Dr. Jeffrey Bradley, Radiation Oncologist at Washington University in St. Louis, provides evidence for the use of stereotactic body radiation therapy as an alternative to surgery for operable early stage lung cancer.


Download Transcript



There has been a growing interest in stereotactic body radiation therapy in the United States and across the world. As patients have come to learn about this, they have sought alternatives to surgery today. Now, surgical techniques have improved — minimally invasive surgery has proven to be quite effective in eradicating early stage lung cancer, but there is a good alternative in stereotactic body radiation therapy, and the literature is coming out now that SBRT probably offers equivalent cure rates and equivalent outcomes to minimally invasive surgery or lobectomy for early stage lung cancer.

The best example of that is a randomized trial published in The Lancet Oncology this past May. It was a randomized trial from two centers, or two groups, one in the United States — an Accuray trial comparing lobectomy to radiosurgery or stereotactic body radiation therapy. The second trial was in the Netherlands, the ROSEL trial, and it also compared patients with lobectomy to stereotactic radiation therapy. Neither trial was able to meet its accrual goals — both under-accrued and were closed due to lack of accrual. So, taken individually, these trials couldn’t give us the answer about this comparison, but the authors and the groups decided to combine the data and publish the data, and the data indicate that SBRT, in this series, proved superior to surgery in this population.

This has caused quite a controversy today. Needless to say, I think stereotactic radiation therapy does offer a reasonable alternative to surgery. Other trials are needed to prove that this is the case since that trial was underpowered to show a true difference, although it does indicate that SBRT is at least equivalent and should be considered for these patients.

Video Language

Next Previous link

Previous PostNext Post

Related Content

Forum Discussions

Hi sbunit and welcome to Grace.  I'm sorry about your mom and you need to be here looking for answers.  Unfortunately there just aren't good answers to these questions.  But yes...

As a follow up to my original question, the specific mutations my mom has are S768l and G719S. It’s very difficult finding concrete information regarding these mutations and treatment outcomes. Was...

Hi patneo and welcome to Grace.  I'm so sorry your wife is going through this.  It isn't possible or even legal to give advice to someone online unless it's in a...

Will doing an ct pet scan to look blood clot in lungs plus onc will be issuing an light dosage of Pemetrexed and carboplatin for a course and after that an...

Hi patneo,


I'm sorry but your wife's situation sounds too complicated to make judgments about possible best practices. I think our language barrier may be complicating our communication as well...because...

Recent Comments

As a follow up to my…
By sbunit on Thu, 11/17/2022 - 16:51
Hi sbunit and welcome to…
By sbunit on Thu, 11/03/2022 - 14:19
I don't know what your first…
By JanineT Forum … on Wed, 11/02/2022 - 12:26
Staying on tagrisso will…
By JanineT Forum … on Wed, 11/02/2022 - 12:17